中文 | English
Return
Total: 38 , 1/4
Show Home Prev Next End page: GO
Author:(Fengxia XUE)

1.Clinical characteristics of aerobic vaginitis and its mixed infectious

Aiping FAN ; Fengxia XUE

Chinese Journal of Obstetrics and Gynecology 2010;45(12):904-908

2.The research progress of Lynch syndrome-associated endometrial cancers

Fei TENG ; Xuegong MA ; Fengxia XUE

Journal of Chinese Physician 2015;17(8):1131-1134

3.How to improve the pregnancy outcome by optimizing embryo cryopreservation protocol

Yue ZHANG ; Yunshan ZHANG ; Fengxia XUE

Tianjin Medical Journal 2015;(3):300-303

4.Recent advances in the research on the relationship between insulin resistance and endometrial cancer

Xuegong MA ; Fengxia XUE ; Yingmei WANG

Chinese Journal of Endocrinology and Metabolism 2012;28(8):680-683

6.Expression and activation of insulin receptor substrate-1 in endometrtal carcinoma

Shaofang HUA ; Fengxia XUE ; Lizhi ZHANG ; Ringmei WANG ; Jing ZHAO

Chinese Journal of Obstetrics and Gynecology 2008;43(6):437-441

7.Clinicopathological characteristics in hereditary nonpolyposis colorectal carcinoma-associated endometrial carcinoma

Yingmei WANG ; Yanbin ZHU ; Fengxia XUE ; Zengyou LIU

Chinese Journal of Obstetrics and Gynecology 2008;43(4):286-289

8.EFFECT OF COLLAGEN POLYPEPTIDES FROM APOSTICHOPUS JAPONICUS ON MELANOGENESIS IN B16 MELANOMA CELLS

Yi WANG ; Jingfeng WANG ; Jin ZHANG ; Fengxia CUI ; Changhu XUE

Acta Nutrimenta Sinica 1956;0(04):-

9.Interpretation of position paper from the World Allergy Organization for IgE allergy diagnostics and other relevant tests in allergy(part one: in vivo tests)

Fengxia XUE ; Changhao ZHANG ; Li XIANG ; Kunling SHEN

Chinese Journal of Applied Clinical Pediatrics 2021;36(6):438-442

10.The clinical analysis of 112 cases with ovarian borderline epithelial tumors

Wen YANG ; Yingmei WANG ; Guoyan LIU ; Ye YAN ; Xuegong MA ; Fengxia XUE

Tianjin Medical Journal 2016;44(9):1092-1094,1095

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 38 , 1/4 Show Home Prev Next End page: GO